AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
SCRT + mFOLFOX6 + PD-1 Antibody + Targeted Therapy for HIgh-Risk pMMR/MSS Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Individualized Comprehensive Treatment for Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Status
- RECRUITING
- Phase
- PHASE2
Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE3
5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The Treatment of Newly Diagnosed CD19+Mixed Phenotype Acute Leukemia in Adults
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Short-Course Radiotherapy Combined with Intracavitary Brachytherapy Followed by Pucotenlimab, Bevacizumab, Oxaliplatin, and Trifluridine/Tipiracil (TAS-102) for Total Neoadjuvant Therapy of Microsatellite Stable (MSS) Locally Advanced Low Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Impact of Vascular Endothelial Growth Factor Gene Polymorphisms on Bevacizumab Efficacy in a Sample of Iraqi Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
JAB-21822 Combined With Chemotherapy and Bevacizumab in Second-line KRAS G12C CRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1